Dae Hwa Pharm Co (XKRX:067080) Other Current Liabilities : ₩4,975 Mil (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Other Current Liabilities?

Dae Hwa Pharm Co's other current liabilities for the quarter that ended in Mar. 2024 was ₩4,975 Mil.

Dae Hwa Pharm Co's quarterly other current liabilities increased from Sep. 2023 (₩3,471 Mil) to Dec. 2023 (₩5,040 Mil) but then declined from Dec. 2023 (₩5,040 Mil) to Mar. 2024 (₩4,975 Mil).

Dae Hwa Pharm Co's annual other current liabilities increased from Dec. 2021 (₩3,652 Mil) to Dec. 2022 (₩4,881 Mil) and increased from Dec. 2022 (₩4,881 Mil) to Dec. 2023 (₩5,040 Mil).

Dae Hwa Pharm Co Other Current Liabilities Historical Data

The historical data trend for Dae Hwa Pharm Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Other Current Liabilities Chart

Dae Hwa Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Dae Hwa Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Dae Hwa Pharm Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Dae Hwa Pharm Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Dae Hwa Pharm Co (XKRX:067080) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Other Current Liabilities

Traded in Other Exchanges

N/A

Address

495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804

Website

http://www.dhpharm.co.kr

Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co (XKRX:067080) Headlines

No Headlines